Prenetics Global Reports Record Q4 & FY2025 Results, IM8 Achieves $120M ARR, $171M Liquidity
Summary
Prenetics Global reported record Q4 and full-year 2025 financial results, driven by its IM8 brand achieving $120 million in annualized recurring revenue within 12 months of launch. The company also completed its strategic transformation, resulting in approximately $171 million in adjusted liquidity and zero debt.
Key Events
-
Record Financial Performance
Full-year 2025 revenue surged 480% to $92.4 million, with Q4 revenue reaching $36.6 million, up 457.1% year-over-year and 55.2% quarter-over-quarter.
-
IM8 Brand Achieves Milestone
The IM8 premium health and longevity brand reached $120 million in annualized recurring revenue (ARR) by December 2025, just 12 months after launch, contributing $60.1 million to FY2025 revenue.
-
Strengthened Balance Sheet
Following the completion of strategic divestitures, the company boasts approximately $171 million in total adjusted liquidity as of February 15, 2026, with zero outstanding debt.
-
Positive Outlook and Guidance
Prenetics reaffirmed its 2026 IM8 revenue guidance of $180 million to $200 million, targeting $250 million to $300 million in ARR by year-end 2026, and expects to achieve adjusted EBITDA profitability by Q4 2027.
Analysis
This filing details a highly successful period for Prenetics Global, marked by exceptional revenue growth and the rapid scaling of its IM8 premium health and longevity brand. The company's strategic divestitures, previously reported on February 17th and January 6th, have significantly strengthened its balance sheet, providing substantial financial capacity for future growth. The reaffirmed strong 2026 guidance for IM8, coupled with a clear path to adjusted EBITDA profitability by Q4 2027, indicates robust operational momentum and a focused strategy. Investors should view these results as a strong validation of the company's strategic shift towards its high-growth consumer health segment.
At the time of this filing, PRE was trading at $21.52 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $365.9M. The 52-week trading range was $3.09 to $22.86. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.